Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

TechnologyAdvice

The genetic makeup of a pharma company

Thinking of your company’s DNA is much more than a figure of speech

- PMLiVE

Merck Serono pulls development of lung cancer prospect

Ditches tecemotide immunotherapy to focus on anti-PD1

- PMLiVE

FDA panel backs Novo Nordisk’s liraglutide for obesity

Committee says diabetes drug could be used to reduce weight

- PMLiVE

AbbVie-partnered Calico unveils first licensing deal

Google’s healthcare research business gains rights to drug prospects in neurodegeneration

- PMLiVE

Pre-chemotherapy indication for Xtandi in prostate cancer

Astellas drug set to compete with J&J’s Zytiga

- PMLiVE

Gopa Mitra retires from PAGB

She steps down after 34 years at organisation

- PMLiVE

The definition of value

Aligning the thoughts of biopharma and other healthcare stakeholders

- PMLiVE

Dive in: gaining leadership in a therapeutic area

Gaining long-term leadership in a therapy area can be commercially invaluable

- PMLiVE

Mylan buys US rights to blood clot drug

$300m deal to acquire Arixtra from South Africa’s Aspen

- PMLiVE

Second time lucky for Takeda’s obesity drug

FDA approves Contrave three years after initial rejection

- PMLiVE

Baxter names biopharma spin-off Baxalta

Will separate from medical technology business

EU flag

Lantus faces first biosimilar rival in Europe

Sanofi prepares for insulin challenge from Boehringer and Lilly

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links